CMCO Stock Analysis: Columbus McKinnon | NASDAQ
Farm & Heavy Construction Machinery | NASDAQ, USA | Market Cap: 391m USD | 12M Return: -19.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.34M
EPS Trend: -89.6%
Qual. Beats: -1
Rev. Trend: 44.3%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Columbus McKinnon Corporation (NASDAQ: CMCO) is an industrial machinery company that designs, manufactures, and markets motion solutions for material handling applications worldwide, including hoists, conveying systems, power control systems, chain and forged products, actuators, crane components, and elevator drives. Founded in 1875 and headquartered in Charlotte, North Carolina, the company operates in the Industrial Machinery & Supplies sector, a category typically characterized by long product life cycles, demand tied to capital expenditure and infrastructure investment, and revenue derived largely from B2B channels.
CMCO serves a broad set of end markets-including industrial automation, construction and infrastructure, energy and utilities, food and beverage, aerospace, mining, entertainment, and warehousing-reaching customers through direct sales, industrial distributors, original equipment manufacturers, government agencies, and engineering, procurement, and construction firms. This diversified end-market exposure and multi-channel distribution model are common risk-mitigation approaches within the capital goods industry, where reliance on a single customer base or geographic region can amplify cyclicality.
- E-commerce warehouse automation lifts conveying systems revenue
- Steel input cost inflation pressures product gross margins
- Industrial automation and EV production orders accelerate
| Net Income: -229.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -4.82 > 1.0 |
| NWC/Revenue: 49.98% < 20% (prev 21.58%; Δ 28.40% < -1%) |
| CFO/TA -0.03 > 3% & CFO -146.2m > Net Income -229.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.7m) vs 12m ago -0.08% < -2% |
| Gross Margin: 29.55% > 18% (prev 33.82%; Δ -4.27% > 0.5%) |
| Asset Turnover: 36.59% > 50% (prev 55.38%; Δ -18.80% > 0%) |
| Interest Coverage Ratio: -2.25 > 6 (EBIT TTM -138.1m / Interest Expense TTM 61.4m) |
| A: 0.12 (Total Current Assets 1.18b - Total Current Liabilities 584.3m) / Total Assets 4.78b |
| B: 0.03 (Retained Earnings 135.8m / Total Assets 4.78b) |
| C: -0.04 (EBIT TTM -138.1m / Avg Total Assets 3.26b) |
| D: 0.43 (Book Value of Equity 1.45b / Total Liabilities 3.34b) |
| Altman-Z'' = 1.08 = BB |
| DSRI: 1.85 (Receivables 380.2m/165.5m, Revenue 1.19b/963.0m) |
| GMI: 1.14 (GM 33.82% / 29.55%) |
| AQI: 1.00 (AQ_t 0.67 / AQ_t-1 0.67) |
| SGI: 1.24 (Revenue 1.19b / 963.0m) |
| TATA: -0.02 (NI -229.5m - CFO -146.2m) / TA 4.78b) |
| Beneish M = -2.03 (Cap -4..+1) = BB |
As of July 11, 2026, the stock is trading at USD 13.24 with a total of 606,757 shares traded. Over the past week, the price has changed by -2.29%, over one month by +9.24%, over three months by -15.12% and over the past year by -19.05%.
Current recommended Stop Loss: 12.20 (which is 7.9% or 1.2 ATR below the current price).
Columbus McKinnon has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CMCO.
- StrongBuy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 24.8 | 86.9% |
P/E Forward = 7.9681
P/S = 0.3274
P/B = 0.5934
P/EG = 0.46
Revenue TTM = 1.19b USD
EBIT TTM = -138.1m USD
EBITDA TTM = -61.0m USD
Long Term Debt = 2.22b USD (from longTermDebt, last quarter)
Short Term Debt = 166.4m USD (from shortTermDebt, last quarter)
Debt = 2.50b USD (from shortLongTermDebtTotal, last quarter) + Leases 107.3m
Net Debt = 2.40b USD (calculated: Debt 2.50b - CCE 96.6m)
Enterprise Value = 2.79b USD (390.7m + Debt 2.50b - CCE 96.6m)
Interest Coverage Ratio = -2.25 (Ebit TTM -138.1m / Interest Expense TTM 61.4m)
EV/FCF = -17.03x (Enterprise Value 2.79b / FCF TTM -164.1m)
FCF Yield = -5.87% (FCF TTM -164.1m / Enterprise Value 2.79b)
FCF Margin = -13.75% (FCF TTM -164.1m / Revenue TTM 1.19b)
Net Margin = -19.23% (Net Income TTM -229.5m / Revenue TTM 1.19b)
Gross Margin = 29.55% ((Revenue TTM 1.19b - Cost of Revenue TTM 840.8m) / Revenue TTM)
Gross Margin QoQ = 23.50% (prev 31.86%)
Tobins Q-Ratio = 0.58 (Enterprise Value 2.79b / Total Assets 4.78b)
Interest Expense / Debt = 2.46% (Interest Expense 61.4m / Debt 2.50b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -109.1m (EBIT -138.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.02 (Total Current Assets 1.18b / Total Current Liabilities 584.3m)
Debt / Equity = 1.73 (Debt 2.50b / totalStockholderEquity, last quarter 1.45b)
Debt / EBITDA = -39.38 (negative EBITDA) (Net Debt 2.40b / EBITDA -61.0m)
Debt / FCF = -14.65 (negative FCF - burning cash) (Net Debt 2.40b / FCF TTM -164.1m)
Total Stockholder Equity = 1.05b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.04% (Net Income -229.5m / Total Assets 4.78b)
RoE = -21.88% (Net Income TTM -229.5m / Total Stockholder Equity 1.05b)
RoCE = -4.23% (EBIT -138.1m / Capital Employed (Equity 1.05b + L.T.Debt 2.22b))
RoIC = -2.53% (negative operating profit) (NOPAT -109.1m / Invested Capital 4.31b)
WACC = 3.62% (E(390.7m)/V(2.89b) * Re(14.35%) + D(2.50b)/V(2.89b) * Rd(2.46%) * (1-Tc(0.21)))
Discount Rate = 14.35% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -51.11 | Cagr: -0.43%
[DCF] Fair Price = unknown (Cash Flow -164.1m)
EPS Correlation: -89.62 | EPS CAGR: -23.20% | SUE: -1.02 | # QB: -1
Revenue Correlation: 44.30 | Revenue CAGR: 2.96% | SUE: 1.70 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.28 | Chg30d=-30.05% | Revisions=-25% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.43 | Chg30d=-13.20% | Revisions=-40% | Analysts=4
EPS current Year (2027-03-31): EPS=1.76 | Chg30d=-1.81% | Revisions=+0% | GrowthEPS=-5.8% | GrowthRev=+75.3%
EPS next Year (2028-03-31): EPS=2.51 | Chg30d=-1.06% | Revisions=+0% | GrowthEPS=+42.3% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: -30% (up=2, down=5)